SENSEONICS HOLDINGS INC (SENS)

US81727U1051 - Common Stock

0.3234  +0.01 (+4.83%)

Premarket: 0.32 0 (-1.05%)

Fundamental Rating

2

SENS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. While SENS seems to be doing ok healthwise, there are quite some concerns on its profitability. SENS is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

SENS had negative earnings in the past year.
SENS had a negative operating cash flow in the past year.
SENS had negative earnings in 4 of the past 5 years.
SENS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SENS has a Return On Assets of -58.21%. This is in the lower half of the industry: SENS underperforms 73.26% of its industry peers.
The Return On Equity of SENS (-109.54%) is worse than 69.52% of its industry peers.
Industry RankSector Rank
ROA -58.21%
ROE -109.54%
ROIC N/A
ROA(3y)-38.59%
ROA(5y)-138.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 12.04%, SENS is not doing good in the industry: 82.89% of the companies in the same industry are doing better.
SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SENS has more shares outstanding
Compared to 5 years ago, SENS has more shares outstanding
Compared to 1 year ago, SENS has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -7.72, we must say that SENS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -7.72, SENS is not doing good in the industry: 75.94% of the companies in the same industry are doing better.
SENS has a Debt/Equity ratio of 0.56. This is a neutral value indicating SENS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.56, SENS is doing worse than 67.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z -7.72
ROIC/WACCN/A
WACC8.53%

2.3 Liquidity

SENS has a Current Ratio of 7.53. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS has a better Current ratio (7.53) than 85.03% of its industry peers.
SENS has a Quick Ratio of 7.03. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.03, SENS belongs to the best of the industry, outperforming 86.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.53
Quick Ratio 7.03

5

3. Growth

3.1 Past

The earnings per share for SENS have decreased strongly by -30.00% in the last year.
SENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.62%.
The Revenue has been growing slightly by 3.43% on average over the past years.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)36.62%
Revenue growth 3Y65.39%
Revenue growth 5Y3.43%
Sales Q2Q%-30.13%

3.2 Future

Based on estimates for the next years, SENS will show a small growth in Earnings Per Share. The EPS will grow by 4.42% on average per year.
The Revenue is expected to grow by 29.59% on average over the next years. This is a very strong growth
EPS Next Y9.56%
EPS Next 2Y8.06%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue Next Year1.64%
Revenue Next 2Y28.01%
Revenue Next 3Y29.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SENS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.06%
EPS Next 3Y4.42%

0

5. Dividend

5.1 Amount

SENS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SENSEONICS HOLDINGS INC

NYSEARCA:SENS (11/11/2024, 8:04:00 PM)

Premarket: 0.32 0 (-1.05%)

0.3234

+0.01 (+4.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap191.66M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.21%
ROE -109.54%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 12.04%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 7.53
Quick Ratio 7.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y9.56%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)36.62%
Revenue growth 3Y65.39%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y